Literature DB >> 35112184

Protective Roles of Xenotropic and Polytropic Retrovirus Receptor 1 (XPR1) in Uremic Vascular Calcification.

Hokuto Arase1, Shunsuke Yamada1, Kumiko Torisu2, Masanori Tokumoto3, Masatomo Taniguchi4, Kazuhiko Tsuruya5, Toshiaki Nakano6, Takanari Kitazono1.   

Abstract

Cellular phosphate transporters play critical roles in the pathogenesis of vascular calcification (VC) in chronic kidney disease (CKD). However, the mechanistic link between VC and xenotropic and polytropic receptor 1 (XPR1), a newly identified phosphate exporter, remains unknown. We developed a new mouse model with rapidly progressive uremic VC in C57BL/6 mice and examined the roles of XPR1. The combination of surgical heminephrectomy and 8 weeks of feeding a customized warfarin and adenine-based diet induced extensive aortic VC in almost all mice. The XPR1 mRNA level in the aorta of CKD mice was significantly lower than those in control mice as early as week 2, when there was no apparent VC, which progressively declined thereafter. Dietary phosphate restriction increased XPR1 mRNA expression in the aorta but reduced aortic VC in CKD mice. In cultured vascular smooth muscle cells (VSMCs), a calcifying medium supplemented with high phosphate and calcium did not affect XPR1 mRNA expression. The XPR1 mRNA expression in cultured VCMCs was also unaffected by administration of indoxyl sulfate or calcitriol deficiency but was decreased by 1-34 parathyroid hormone or fibroblast growth factor 23 supplementation. Furthermore, XPR1 deletion in the cultured VSMCs exacerbated calcification of the extracellular matrix as well as the osteogenic phenotypic switch under the condition of calcifying medium. Our data suggest that XPR1 plays protective roles in the pathogenesis of VC and its decrease in the aorta may contribute to the progression of VC in CKD.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Mouse model; Phosphate transporter; Vascular calcification; Vascular smooth muscle cell; XPR1

Mesh:

Substances:

Year:  2022        PMID: 35112184     DOI: 10.1007/s00223-022-00947-3

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  37 in total

1.  Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease.

Authors:  J Blacher; A P Guerin; B Pannier; S J Marchais; G M London
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

2.  Indoxyl Sulfate and p-Cresyl Sulfate Promote Vascular Calcification and Associate with Glucose Intolerance.

Authors:  Britt Opdebeeck; Stuart Maudsley; Abdelkrim Azmi; Annelies De Maré; Wout De Leger; Bjorn Meijers; Anja Verhulst; Pieter Evenepoel; Patrick C D'Haese; Ellen Neven
Journal:  J Am Soc Nephrol       Date:  2019-04-02       Impact factor: 10.121

3.  Indoxyl sulfate-induced calcification of vascular smooth muscle cells via the PI3K/Akt/NF-κB signaling pathway.

Authors:  Xin He; Hongli Jiang; Fanfan Gao; Shanshan Liang; Meng Wei; Lei Chen
Journal:  Microsc Res Tech       Date:  2019-08-25       Impact factor: 2.769

4.  Klotho deficiency causes vascular calcification in chronic kidney disease.

Authors:  Ming Chang Hu; Mingjun Shi; Jianning Zhang; Henry Quiñones; Carolyn Griffith; Makoto Kuro-o; Orson W Moe
Journal:  J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 10.121

5.  Association of serum phosphate with vascular and valvular calcification in moderate CKD.

Authors:  Kathryn L Adeney; David S Siscovick; Joachim H Ix; Stephen L Seliger; Michael G Shlipak; Nancy S Jenny; Bryan R Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 10.121

Review 6.  Vascular calcification: in vitro evidence for the role of inorganic phosphate.

Authors:  Cecilia M Giachelli
Journal:  J Am Soc Nephrol       Date:  2003-09       Impact factor: 10.121

7.  High phosphate feeding promotes mineral and bone abnormalities in mice with chronic kidney disease.

Authors:  Wei Ling Lau; Michael Linnes; Emily Y Chu; Brian L Foster; Bryan A Bartley; Martha J Somerman; Cecilia M Giachelli
Journal:  Nephrol Dial Transplant       Date:  2012-10-08       Impact factor: 5.992

8.  Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

Authors:  Gérard M London; Alain P Guérin; Sylvain J Marchais; Fabien Métivier; Bruno Pannier; Hasan Adda
Journal:  Nephrol Dial Transplant       Date:  2003-09       Impact factor: 5.992

9.  Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.

Authors:  Mario Cozzolino; Mark E Staniforth; Helen Liapis; Jane Finch; Steven K Burke; Adriana S Dusso; Eduardo Slatopolsky
Journal:  Kidney Int       Date:  2003-11       Impact factor: 10.612

10.  A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients.

Authors:  Teresa Adragao; Ana Pires; Carlos Lucas; Rita Birne; Luís Magalhaes; Margarida Gonçalves; Acácio Pita Negrao
Journal:  Nephrol Dial Transplant       Date:  2004-03-19       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.